Nervous System Diseases: News and Research on Autoimmune Diseases of the Nervous System

MeSH tree: C10.114

How a multiple sclerosis drug reshapes the immune system

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that depletes B cells—the immune ...

New potential drug targets for multiple sclerosis identified

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the way for new treatment ...

Blood test might predict MS relapse

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.

The many ways that AI enters rheumatology

Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from data, identify patterns, and make decisions. But how can it be used to support health care? EULAR—The ...

page 18 from 40